November 15th, 2026Five Under 5: Top Oncology Videos for the Week of 11/8The top 5 OncLive TV videos of the week cover insights in HER2+ breast cancer, NSCLC, ovarian cancer, prostate cancer, and sarcoma.Read more
November 14th, 2026The OncFive: Top Oncology Articles for the Week of 11/8The FDA approved pimicotinib for tenosynovial giant cell tumor, accepted a gedatolisib filing in advanced breast cancer, and more.Read more
November 13th, 2026OncLive Weekly News Quiz (11/13/2026): Did You Miss Crucial TGCT, Breast Cancer, Bladder Cancer, and Lymphoma Updates?Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.Read more
November 10th, 2026FDA Approves Pimicotinib for Symptomatic TGCTThe FDA has approved pimicotinib for patients with symptomatic tenosynovial giant cell tumors.Read more
November 7th, 2026Afami-Cel Outcomes Are Tied to MAGE-A4 Expression, Tumor Burden in Synovial SarcomaA post hoc analysis of SPEARHEAD-1 found that MAGE-A4 H-score was independently tied to response and progression-free survival, whereas baseline tumor burden was tied to overall survival.Read more